This clinical audit aims to improve the management of patients with iron deficiency following oral or IV iron supplementation.
Find out about the new management recommendations for chronic kidney disease in the new Chronic Kidney Disease (CKD) Management in Primary Care (4th Edition) handbook, released in 2020.
Diabetes doesn't stop for a pandemic. This on-demand webinar will outline pragmatic ways that GPs play crucial roles in proactively managing diabetes during this pandemic. The presenters will show how to identify diabetes 'red flags' during this pandemic, and provide simple steps, resources and tips that will promote optimal diabetes patient health and address individual patient risks.
Diabetes is one of the most common chronic conditions in Australia today, and its management relies upon effective glycaemic control to minimise the risk of complications. This module aims to improve GP understanding of how to optimise insulin in type 2 diabetes.
Dementia in primary care: Recognising and managing behavioural and psychological symptoms and physical comorbidities
Behavioural and psychological symptoms of dementia (BPSD) can lead to quality of life impacts in not only the individual with dementia, but also others around them. This module explores the assessment of BPSD using the ABC (antecedent, behaviour, consequence) model, and discusses the management of BPSD using pharmacological and non-pharmacological methods as well as the management of comorbid conditions associated with dementia.
Coordination of care between the patient, their carer and their family is vital to providing effective end-of-life care in people with dementia. This education explores support and education for carers of people with dementia, as well as end-of-life issues such as legal processes, palliative care and community support.
This module aims to improve GP confidence in managing early schizophrenia, including identifying and managing negative symptoms to reduce disability for their patients.
Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.
Hereditary mutations of the tumour suppressor genes BRCA1 and BRCA2 can lead to an elevated risk of breast cancer. This education explores how to identify affected patients with a family history of cancer, and provides an overview of how Familial Cancer Centres can assist these patients through genetic testing and risk management.